Atherosclerotic plaque detected by transesophageal echocardiography is an independent predictor for all-cause mortality.


Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 20 11 2019
accepted: 06 04 2020
pubmed: 18 4 2020
medline: 6 10 2020
entrez: 18 4 2020
Statut: ppublish

Résumé

Atherosclerotic lesions in the great arteries are frequent findings in the elderly. Numerous studies have shown their strong predictive value for cardiovascular disease, embolic events, and mortality. We sought to determine the risk of all-cause mortality depending on the localization of plaques in the thoracic aorta evaluated by transesophageal echocardiography (TEE). A total of 2,054 patients (median age 65 years, interquartile range 52-73; 58% men) who underwent a TEE examination between 01/2007 and 03/2015 were retrospectively analyzed. For each patient, the presence of atherosclerotic lesions in the ascending aorta, the aortic arch, and in the descending aorta, as well as cardiovascular risk factors and survival were documented. Median follow-up period was 48 months (interquartile range 38-58). Multivariate Cox regression analysis indicated plaque in the ascending aorta (HR of 1.36, 95% CI 1.01-1.83, P = 0.046), the aortic arch (HR of 1.78, 95% CI 1.29-2.45, P < 0.001), the descending aorta (HR of 2.01, 95% CI 1.54-2.77, P < 0.001), and plaque in any part of the thoracic aorta (HR of 1.84, 95% CI 1.42-2.4, P < 0.001), as independent predictors for all-cause mortality after adjusting for age, sex, arterial hypertension, hyperlipidemia, smoking, and diabetes. In this study, we could demonstrate that more than mild plaque at any site of the thoracic aorta predicts all-cause mortality. Assessment of atherosclerotic lesions in all segments of the thoracic aorta should be part of every routine TEE examination.

Identifiants

pubmed: 32301042
doi: 10.1007/s10554-020-01840-6
pii: 10.1007/s10554-020-01840-6
pmc: PMC7381477
doi:

Types de publication

Journal Article Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

1437-1443

Références

Am J Cardiol. 2009 Mar 1;103(5):713-7
pubmed: 19231339
Cardiovasc Ultrasound. 2004 Oct 22;2:21
pubmed: 15500685
J Hypertens. 1994 Sep;12(9):989-99
pubmed: 7852757
Intern Med. 1999 Oct;38(10):766-72
pubmed: 10526938
J Am Coll Cardiol. 1996 Oct;28(4):942-7
pubmed: 8837572
Atherosclerosis. 2010 Mar;209(1):131-5
pubmed: 19782363
Mayo Clin Proc. 1999 Sep;74(9):862-9
pubmed: 10488786
Am J Cardiol. 2011 Jan 15;107(2):175-8
pubmed: 21129720
Cerebrovasc Dis. 2013;36(1):26-32
pubmed: 23920380
Circulation. 2010 Feb 23;121(7):870-8
pubmed: 20177005
Stroke. 2014 Jun;45(6):1764-70
pubmed: 24788969
Lancet Neurol. 2004 Jul;3(7):408-14
pubmed: 15207797
Atherosclerosis. 2000 Oct;152(2):451-6
pubmed: 10998474
Anesth Analg. 1996 Oct;83(4):701-8
pubmed: 8831306
Am Heart J. 1990 Sep;120(3):658-60
pubmed: 2389701
J Am Coll Cardiol. 1994 Apr;23(5):1085-90
pubmed: 8144773
Stroke. 2010 Jun;41(6):1145-50
pubmed: 20431080
Eur J Radiol. 2016 Nov;85(11):2030-2035
pubmed: 27776656
Circ J. 2010 Oct;74(10):2152-7
pubmed: 20689218
J Am Coll Cardiol. 1999 Apr;33(5):1317-22
pubmed: 10193733
N Engl J Med. 1994 Dec 1;331(22):1474-9
pubmed: 7969297
Ann Card Anaesth. 2016 Oct;19(Supplement):S44-S55
pubmed: 27762248
Circulation. 2007 Aug 21;116(8):928-35
pubmed: 17684150
J Am Coll Cardiol. 1996 Jan;27(1):95-101
pubmed: 8522717
Circ J. 2013;77(1):68-72
pubmed: 23047295
Eur J Echocardiogr. 2010 Sep;11(8):645-58
pubmed: 20823280
Ann Thorac Surg. 2017 Oct;104(4):1325-1331
pubmed: 28577841
Eur J Neurol. 2016 Mar;23(3):569-79
pubmed: 26918744

Auteurs

Houtan Heidari (H)

Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Wien, Austria.

Hong Ran (H)

Department of Echocardiography, Nanjing First Hospital Affiliated to Nanjing Medical University, Nanjing, China.

Georg Spinka (G)

Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Wien, Austria.

Christian Hengstenberg (C)

Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Wien, Austria.

Thomas Binder (T)

Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Wien, Austria.

Georg Goliasch (G)

Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Wien, Austria.

Matthias Schneider (M)

Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Wien, Austria. matthias.schneider@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH